Condition : Rheumatoid Arthritis Interventions : Drug: rituximab [MabThera/Rituxan]; Drug: methotrexate; Drug: methylprednisolone Sponsor : Hoffmann-La Roche Recruiting - verified July 2011

This study aims to collect Australian data on the prevalence of undiagnosed psoriatic arthritis in patients with plaque psoriasis. In addition the study will assess disease severity and quality of lif...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: DMARDs (disease-modifying antirheumatic drugs) Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed -...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: DMARDs Sponsor : Hoffmann-La Roche Not yet recruiting - verified July 2011

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: DMARDs (disease-modifying antirheumatic drugs) Sponsor : Hoffmann-La Roche Recruiting - verified July 2011

Condition : Juvenile Idiopathic Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: tocilizumab [RoActemra/Actemra]; Drug: tocilizumab [RoActemra/Actemra]; Drug: placebo; Drug: NSAI...

Condition : Juvenile Idiopathic Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: tocilizumab [RoActemra/Actemra]; Drug: tocilizumab [RoActemra/Actemra]; Drug: placebo; Drug: NSAI...

Condition : Osteoarthritis, Knee Interventions : Procedure: TKA surgery with modular polished tibial baseplate/XLK design; Procedure: TKA surgery with the nonmodular APT/GVF design; Device: P.F.C.® Si...

To explore the effect of CP-690,550 on blood and synovial markers in subjects with rheumatoid arthritis. To evaluate the safety, tolerability and efficacy of CP-690,550.

To explore the effect of CP-690,550 on blood and synovial markers in subjects with rheumatoid arthritis. To evaluate the safety, tolerability and efficacy of CP-690,550.